Please use this identifier to cite or link to this item:
http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/7607Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Rajasooriyar, C. | |
| dc.contributor.author | Moorthy, T. | |
| dc.contributor.author | Ranatunge, N. | |
| dc.contributor.author | Ginige, A. | |
| dc.contributor.author | Surenthirakumaran, R. | |
| dc.date.accessioned | 2022-09-26T05:46:35Z | - |
| dc.date.available | 2022-09-26T05:46:35Z | - |
| dc.date.issued | 2020 | |
| dc.identifier.citation | Proceedings JMA-September - 2020 | en_US |
| dc.identifier.uri | http://repo.lib.jfn.ac.lk/ujrr/handle/123456789/7607 | - |
| dc.language.iso | en | en_US |
| dc.publisher | Jaffna Medical Association | en_US |
| dc.subject | Esophageal cancer | en_US |
| dc.subject | Tyrosine kinase inhibitors | en_US |
| dc.subject | Mutation | en_US |
| dc.title | Significant incidence of braf p.V600E mutations in esophageal cancer sets the stage for potential use of tyrosine kinase inhibitors | en_US |
| dc.type | Research abstract | en_US |
| Appears in Collections: | Community & Family Medicine | |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.
